Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...